Radionuclide Therapy Scholarly Peer-review Journal|OMICS International|Journal Of Nuclear Medicine And Radiation Therapy

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Radionuclide Therapy

Radionuclide therapy uses high dose Radio-active isotopes combined with peptides or hormones, which help in targeting a specific organ for which the hormone is attracted to. This combination enables to radioactive isotope to specifically target a tissue where tumor exist and helps to completely eradicate and kill tumor cells. Unlike, external radiation Radionuclide therapy can be given orally to treat systemic cancer. Scholarly peer review is the process of subjecting an author's scholarly work, research, or ideas to the scrutiny of others who are experts in the same field, before a paper describing this work is published in a journal. The work may be accepted, considered acceptable with revisions, or rejected. Peer review requires a community of experts in a given (narrowly defined) field, who are qualified and able to perform reasonably impartial review.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2021